<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37791472</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1554-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of neuropathology and experimental neurology</Title><ISOAbbreviation>J Neuropathol Exp Neurol</ISOAbbreviation></Journal><ArticleTitle>C9orf72 proline-arginine dipeptide repeats disrupt the proteasome and perturb proteolytic activities.</ArticleTitle><Pagination><StartPage>901</StartPage><EndPage>910</EndPage><MedlinePgn>901-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jnen/nlad078</ELocationID><Abstract><AbstractText>The hexanucleotide G4C2 repeat expansion in C9orf72 is the most frequent genetic cause of familial amyotrophic lateral sclerosis (ALS). Aberrant translation of this hexanucleotide sequence leads to production of 5 dipeptide repeats (DPRs). One of these DPRs is proline-arginine (polyPR), which is found in C9orf72-expanded ALS (C9ALS) patient brain tissue and is neurotoxic across multiple model systems. PolyPR was previously reported to bind and impair proteasomes in vitro. Nevertheless, the clinical relevance of the polyPR-proteasome interaction and its functional consequences in vivo are yet to be established. Here, we aim to confirm and functionally characterize polyPR-induced impairment of proteolysis in C9ALS patient tissue and an in vivo model system. Confocal microscopy and immunofluorescence studies on both human and Drosophila melanogaster brain tissues revealed sequestration of proteasomes by polyPR into inclusion-like bodies. Co-immunoprecipitation in D. melanogaster showed that polyPR strongly binds to the proteasome. In vivo, functional evidence for proteasome impairment is further shown by the accumulation of ubiquitinated proteins along with lysosomal accumulation and hyper-acidification, which can be rescued by a small-molecule proteasomal enhancer. Together, we provide the first clinical report of polyPR-proteasome interactions and offer in vivo evidence proposing polyPR-induced proteolytic dysfunction as a pathogenic mechanism in C9ALS.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of American Association of Neuropathologists, Inc. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology, Haverford College, Haverford, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Sophia C K</ForeName><Initials>SCK</Initials><AffiliationInfo><Affiliation>Department of Biology, Haverford College, Haverford, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viera Ortiz</LastName><ForeName>Ashley P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 613A Stellar Chance Laboratories, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 613A Stellar Chance Laboratories, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fairman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8103-0783</Identifier><AffiliationInfo><Affiliation>Department of Biology, Haverford College, Haverford, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P40 OD018537</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095793</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30AG072979</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neuropathol Exp Neurol</MedlineTA><NlmUniqueID>2985192R</NlmUniqueID><ISSNLinking>0022-3069</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>9DLQ4CIU6V</RegistryNumber><NameOfSubstance UI="D011392">Proline</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011392" MajorTopicYN="N">Proline</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
          C9orf72
        </Keyword><Keyword MajorTopicYN="N">
          Drosophila melanogaster
        </Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Proteasome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37791472</ArticleId><ArticleId IdType="pmc">PMC10587997</ArticleId><ArticleId IdType="doi">10.1093/jnen/nlad078</ArticleId><ArticleId IdType="pii">7288388</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, et al.Motor neuron susceptibility in ALS/FTD. Front Neurosci 2019;13:532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245&#x2013;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohki Y, Wenninger-Weinzierl A, Hruscha A, et al.Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration. Mol Neurodegener 2017;12:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237533</ArticleId><ArticleId IdType="pubmed">28088213</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM.. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat Rev Neurol 2018;14:544&#x2013;558</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Hasan GM, Hassan MI.. Unraveling the role of RNA mediated toxicity of C9orf72 repeats in C9-FTD/ALS. Front Neurosci 2017;11:711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736982</ArticleId><ArticleId IdType="pubmed">29326544</ArticleId></ArticleIdList></Reference><Reference><Citation>Babic Leko M, Zupunski V, Kirincich J, et al.Molecular mechanisms of neurodegeneration related to C9orf72 hexanucleotide repeat expansion. Behav Neurol 2019;2019:2909168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350563</ArticleId><ArticleId IdType="pubmed">30774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, et al.Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 2013;126:829&#x2013;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Liu L, Tao Z, et al.Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat Commun 2019;10:2906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al.Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 2014;84:1213&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Finley D.. Regulation of proteasome activity in health and disease. Biochim Biophys Acta 2014;1843:13&#x2013;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858528</ArticleId><ArticleId IdType="pubmed">23994620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K. The proteasome: Overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci 2009;85:12&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3524306</ArticleId><ArticleId IdType="pubmed">19145068</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaudeau TA, Smith DM.. A practical review of proteasome pharmacology. Pharmacol Rev 2019;71:170&#x2013;197</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423620</ArticleId><ArticleId IdType="pubmed">30867233</ArticleId></ArticleIdList></Reference><Reference><Citation>Anbanandam A, Albarado DC, Tirziu DC, et al.Molecular basis for proline- and arginine-rich peptide inhibition of proteasome. J Mol Biol 2008;384:219&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2632303</ArticleId><ArticleId IdType="pubmed">18823992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaczynska M, Osmulski PA, Gao Y, et al.Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity. Biochemistry 2003;42:8663&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pubmed">12873125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Lan M, Mojsilovic-Petrovic J, et al.The proline/arginine dipeptide from hexanucleotide repeat expanded C9ORF72 inhibits the proteasome. eNeuro 2017;4:ENEURO.0249-16.2017</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5282547</ArticleId><ArticleId IdType="pubmed">28197542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Haney MS, Morgens DW, et al.CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat Genet 2018;50:603&#x2013;612</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Lecker S, Post MJ, et al.Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. J Clin Invest 2000;106:439&#x2013;48</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314329</ArticleId><ArticleId IdType="pubmed">10930447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gi&#x17c;y&#x144;ska M, Witkowska J, Karpowicz P, et al.Proline- and arginine-rich peptides as flexible allosteric modulators of human proteasome activity. J Med Chem 2019;62:359&#x2013;370</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6796967</ArticleId><ArticleId IdType="pubmed">30452262</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashiro Y, Urushitani M, Inoue H, et al.Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem 2012;287:42984&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3522293</ArticleId><ArticleId IdType="pubmed">23095749</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterwalder T, Yoon KS, White BH, et al.A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci U S A 2001;98:12596&#x2013;601</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60099</ArticleId><ArticleId IdType="pubmed">11675495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JS, Luo L.. A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat Protoc 2006;1:2110&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">17487202</ArticleId></ArticleIdList></Reference><Reference><Citation>Atilano ML, Gronke S, Niccoli T, et al.Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in Drosophila. eLife 2021;10:e58565</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007214</ArticleId><ArticleId IdType="pubmed">33739284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gronke S, Niccoli T, et al.C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 2014;345:1192&#x2013;1194</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>West RJH, Sharpe JL, Voelzmann A, et al.Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age- and combination-specific phenotypic profiles in Drosophila. Acta Neuropathol Commun 2020;8:158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487709</ArticleId><ArticleId IdType="pubmed">32894207</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuva-Aydemir Y, Almeida S, Gao FB.. Insights into C9ORF72-related ALS/FTD from Drosophila and iPSC models. Trends Neurosci 2018;41:457&#x2013;469</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015541</ArticleId><ArticleId IdType="pubmed">29729808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bence NF, Sampat RM, Kopito RR.. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pubmed">11375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleiger G, Mayor T.. Perilous journey: A tour of the ubiquitin-proteasome system. Trends Cell Biol 2014;24:352&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4037451</ArticleId><ArticleId IdType="pubmed">24457024</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB, Nie Z, Batlevi Y, et al.HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007;447:859&#x2013;63</Citation><ArticleIdList><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BH, Lee MJ, Park S, et al.Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010;467:179&#x2013;84</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939003</ArticleId><ArticleId IdType="pubmed">20829789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballabio A, Bonifacino JS.. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol 2020;21:101&#x2013;118</Citation><ArticleIdList><ArticleId IdType="pubmed">31768005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M, Li P, Wang C, et al.Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell 2022;185:2292&#x2013;308 e20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236176</ArticleId><ArticleId IdType="pubmed">35750034</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Ren D.. Lysosomal physiology. Annu Rev Physiol 2015;77:57&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524569</ArticleId><ArticleId IdType="pubmed">25668017</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP.. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci 2017;10:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson Y, Robinson AC, Liu X, et al.Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Neuropathol Appl Neurobiol 2016;42:242&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832296</ArticleId><ArticleId IdType="pubmed">26538301</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Grasser FA, et al.Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol 2015;130:845&#x2013;61</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Daigle JG, Cunningham KM, et al.Stress granule assembly disrupts nucleocytoplasmic transport. Cell 2018;173:958&#x2013;71 e17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi KY, Mori E, Nizami ZF, et al.Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc Natl Acad Sci U S A 2017;114:E1111&#x2013;E7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, et al.Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 2016;92:383&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Woehlbier U, Manque PA.. The enigmatic role of C9ORF72 in autophagy. Front Neurosci 2017;11:442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5541066</ArticleId><ArticleId IdType="pubmed">28824365</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, et al.Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J 2020;39:e100574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>